Metabolism of substrates incorporated into phospholipid vesicles by mouse 25-hydroxyvitamin D3 1α-hydroxylase (CYP27B1)

Journal of Steroid Biochemistry and Molecular Biology

Volumn 119, Issue 3-5, 2010, Pages 171-179

  Tang, Edith K Y ^a   Voo, Kimberley J Q ^a   Nguyen, Minh N ^a   Tuckey, Robert C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

25 Hydroxyvitamin D3; CYP27B1; Cytochrome P450; Phospholipid vesicles; Vitamin D

Indexed keywords

20 HYDROXYVITAMIN D3; 24,25 DIHYDROXYCOLECALCIFEROL; CALCITRIOL; CARDIOLIPIN; COLECALCIFEROL; CYTOCHROME P450; CYTOCHROME P450 27B1; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONCENTRATION PROCESS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SUBSTRATE; MEMBRANE COMPONENT; MITOCHONDRIAL MEMBRANE; NONHUMAN; PHOSPHOLIPID VESICLE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STEROID HYDROXYLATION; VITAMIN D METABOLISM;

24,25-DIHYDROXYVITAMIN D 3; 25-HYDROXYVITAMIN D 2; 25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADRENODOXIN; ANIMALS; CALCIFEDIOL; CARDIOLIPINS; DIMYRISTOYLPHOSPHATIDYLCHOLINE; KINETICS; MICE; MITOCHONDRIAL MEMBRANES; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SPECTROPHOTOMETRY; SUBSTRATE SPECIFICITY; UNILAMELLAR LIPOSOMES;

ESCHERICHIA COLI;

EID: 77950301126     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.02.022     Document Type: Article

References (53)

1. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 2004, 79(3):362-371.
2. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 2004, 29(12):664-673.
3. Bikle D. Nonclassic actions of vitamin D. J. Clin. Endocrinol. Metab. 2009, 94(1):26-34.
4. Bouillon R., Eelen G., Verlinden L., Mathieu C., Carmeliet G., Verstuyf A. Vitamin D and cancer. J. Steroid Biochem. Mol. Biol. 2006, 102(1-5):156-162.
5. 3 production by human keratinocytes. J. Clin. Invest 1986, 78(2):557-566.
6. Holick M.F. Vitamin D: a millennium perspective. J. Cell Biochem. 2003, 88(2):296-307.
7. 3-1α-hydroxylase) of bovine kidney mitochondria. Biochem. Biophys. Res. Commun. 1982, 105(1):320-327.
8. 3 1α-hydroxylase from rat kidney mitochondria. FEBS Lett. 1997, 419(1):45-48.
9. Uchida E., Kagawa N., Sakaki T., Urushino N., Sawada N., Kamakura M., Ohta M., Kato S., Inouye K. Purification and characterization of mouse CYP27B1 overproduced by an Escherichia coli system coexpressing molecular chaperonins GroEL/ES. Biochem. Biophys. Res. Commun. 2004, 323(2):505-511.
10. Tuckey R.C. Progesterone synthesis by the human placenta. Placenta 2005, 26(4):273-281.
11. Headlam M.J., Wilce M.C.J., Tuckey R.C. The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane. Biochim. Biophys. Acta Biomembr. 2003, 1617(1-2):96-108.
12. Pikuleva I.A. Cholesterol-metabolizing cytochromes P450. Drug Metab. Dispos. 2006, 34(4):513-520.
13. Pikuleva I.A., Mast N., Liao W., Turko I.V. Studies of membrane topology of mitochondrial cholesterol hydroxylases CYPs 27A1 and 11A1. Lipids 2008, 43(12):1127-1132.
14. Storbeck K., Swart P., Swart A.C. Cytochrome P450 side-chain cleavage: insights gained from homology modeling. Mol. Cell Endocrinol. 2007, 265-266:65-70.
15. Guryev O., Carvalho R.A., Usanov S., Gilep A., Estabrook R.W. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc. Natl. Acad. Sci. U.S.A. 2003, 100(25):14754-14759.
16. Nguyen M.N., Slominski A., Li W., Ng Y.R., Tuckey R.C. Metabolism of vitamin D2 to 17,20,24-trihydroxyvitamin D2 by cytochrome P450scc (CYP11A1). Drug Metab. Dispos. 2009, 37(4):761-767.
17. Slominski A., Semak I., Zjawiony J., Wortsman J., Li W., Szczesniewski A., Tuckey R.-C. The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J. 2005, 272(16):4080-4090.
18. Tuckey R.C., Li W., Zjawiony J.K., Zmijewski M.A., Nguyen M.N., Sweatman T., Miller D., Slominski A. Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc (CYP11A1). FEBS J. 2008, 275(10):2585-2596.
19. Lambeth J.D., Kitchen S.E., Farooqui A.A., Tuckey R., Kamin H. Cytochrome P-450scc-substrate interactions. Studies of binding and catalytic activity using hydroxycholesterols. J. Biol. Chem. 1982, 257(4):1876-1884.
20. 3-derivatives into liposomes of different lipid types. J. Drug Target. 1994, 2(5):411-417.
21. Tuckey R.C., Stevenson P.M. Properties of ferredoxin reductase and ferredoxin from the bovine corpus luteum. Int. J. Biochem. 1984, 16(5):489-495.
22. 3 1α-hydroxylase and vitamin D synthesis. Science 1997, 277(5333):1827-1830.
23. Sakaki T., Sawada N., Takeyama K.I., Kato S., Inouye K. Enzymatic properties of mouse 25-hydroxyvitamin D3 1α-hydroxylase expressed in Escherichia coli. Eur. J. Biochem. 1999, 259(3):731-738.
24. Wada A., Waterman M.R. Identification by site-directed mutagenesis of two lysine residues in cholesterol side chain cleavage cytochrome P450 that are essential for adrenodoxin binding. J. Biol. Chem. 1992, 267(32):22877-22882.
25. Stromstedt M., Waterman M.R. A full-length cDNA encoding mouse adrenodoxin. Biochim. Biophys. Acta 1995, 1261(1):126-128.
26. Woods S.T., Sadleir J., Downs T., Triantopoulos T., Headlam M.J., Tuckey R.C. Expression of catalytically active human cytochrome P450scc in Escherichia coli and mutagenesis of isoleucine-462. Arch. Biochem. Biophys. 1998, 353(1):109-115.
27. Lambeth J.D., Kamin H., Seybert D.W. Phosphatidylcholine vesicle reconstituted P-450scc. Role of the membrane in control of activity and spin state of the cytochrome. J. Biol. Chem. 1980, 255(17):8282-8288.
28. Tuckey R.C., Janjetovic Z., Li W., Nguyen M.N., Zmijewski M.A., Zjawiony J.K., Slominski A. Metabolism of 1α-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1α,20-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 2008, 112(4-5):213-219.
29. Tuckey R.C., Nguyen M.N., Slominski A. Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrin. Int. J. Biochem. Cell Biol. 2008, 40(11):2619-2626.
30. Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 1964, 239(7):2370-2378.
31. Tuckey R.C., Holland J.F. Comparison of pregnenolone synthesis by cytochrome P-450scc in mitochondria from porcine corpora lutea and granulosa cells of follicles. J. Biol. Chem. 1989, 264(10):5704-5709.
32. Pesce M.A., Strande C.S. A new micromethod for determination of protein in cerebrospinal fluid and urine. Clin. Chem. 1973, 19(11):1265-1267.
33. scc. Mechanism of electron transport by adrenodoxin. J. Biol. Chem. 1980, 255(7):2057-3061.
34. Korzekwa K.R., Krishnamachary N., Shou M., Ogai A., Parise R.A., Rettie A.E., Gonzalez F.J., Tracy T.S. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 1998, 37(12):4137-4147.
35. Lin Y., Lu P., Tang C., Mei Q., Sandig G., Rodrigues A.D., Rushmore T.H., Shou M. Substrate inhibition kinetics for cytochrome P450-catalysed reactions. Drug Metab. Dispos. 2001, 29(4):368-374.
36. Zhou S. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr. Drug Metab. 2008, 9(4):310-322.
37. Janjetovic Z., Zmijewski M.A., Tuckey R.C., DeLeon D.A., Nguyen M.N., Pfeffer L.M., Slominski A.T. 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-κB activity by increasing IκBα levels in human keratinocytes. PLoS ONE 2009, 4(6):e5988. 10.1371/journal.pone.0005988.
38. Zbytek B., Janjetovic Z., Tuckey R.C., Zmijewski M.A., Sweatman T.W., Jones E., Nguyen M.N., Slominski A.T. 20-hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocytes differentiation. J. Invest. Dermatol. 2008, 128:2271-2280.
39. Cunningham N.S., Lee B.S., Henry H.L. The renal mitochondrial metabolism of 25-hydroxyvitamin D-3: a possible role for phospholipids. Biochim. Biophys. Acta 1986, 881(1):480-488. 64.
40. Tuckey R.C., Stevenson P.M. Purification and analysis of phospholipids in the inner mitochondrial membrane fraction of the bovine corpus luteum, and properties of cytochrome P-450scc incorporated into vesicles prepared from these phospholipids. Eur. J. Biochem. 1985, 148(2):379-384.
41. Urushino N., Yamamoto K., Kagawa N., Ikushiro S., Kamakura M., Yamada S., Kato S., Inouye K., Sakaki T. Interaction between mitochondrial CYP27B1 and adrenodoxin: role of arginine 458 of mouse CYP27B1. Biochemistry 2006, 45(14):4405-4412.
42. Tuckey R.C., Kamin H. Kinetics of the incorporation of adrenal cytochrome P-450scc into phosphatidylcholine vesicles. J. Biol. Chem. 1982, 257(6):2887-2893.
43. Kisselev P., Tuckey R.C., Woods S., Triantopolous T., Schwarz D. Enzymatic properties of vesicle-reconstituted human cytochrome P450scc (CYP11A1). Differences in functioning of the mitochondrial electron transfer chain using human and bovine adrenodoxin and activation by cardiolipin. Eur. J. Biochem. 1999, 260(3):768-773.
44. 2. Biochemistry 1975, 14(6):1250-1256.
45. A.T. Slominski, Z. Janjetovic, B. Fuller, M.A. Zmijewski, R.C. Tuckey, M.N. Nguyen, T. Sweatman, W. Li, J. Zjawiony, D. Miller, T.C. Chen, G. Lozanski, M.F. Holick, Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity, PloS ONE (2010), in press.
46. 3 whose mutation causes vitamin D-dependent rickets type 1. J. Biol. Chem. 2005, 280(34):30511-30516.
47. 3 1α-hydroxylase. Coexpression with adrenodoxin and NADPH-adrenodoxin resuctase in Escherichia coli. Eur. J. Biochem. 1999, 265:950-956.
48. Hanukoglu I., Hanukoglu Z. Stoichiometry of mitochondrial cytochromes P-450, adrenodoxin and adrenodoxin reductase in adrenal cortex and corpus luteum. Implications for membrane organization and gene regulation. Eur. J. Biochem. 1986, 157(1):27-31.
49. Tuckey R.C., Kostadinovic Z., Stevenson P.M. Ferredoxin and cytochrome P-450scc concentrations in granulosa cells of porcine ovaries during follicular cell growth and luteinisation. J. Steroid Biochem. 1988, 31(2):201-205.
50. Tuckey R.C., Woods S.T., Tajbakhsh M. Electron transfer to cytochrome P-450scc limits cholesterol side-chain-cleavage activity in the human placenta. Eur. J. Biochem. 1997, 244(3):835-839.
51. Maruya N., Hiwatashi A., Ichikawa Y., Yamano T. Purification and characterization of renal ferredoxin form bovine renal mitochondria. J. Biochem. 1983, 93(5):1239-1247.
52. 3 1α-hydroxylase in rat kidney mitochondria. Anal. Biochem. 1998, 258(1):53-58.
53. 3 hydroxylation by CYP27B1 and CYP24A1. Drug Metab. Dispos. 2007, 35(9):1482-1488.